Diagnostic Efficacy of Serum Asialo α1-Acid Glycoprotein Levels for Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Compared to That in Healthy Subjects: A Prospective Study

Background: Serum asialo α1-acid gycoprotein (AsAGP) is a novel biomarker specific to liver fibrosis. Aim: To evaluate the diagnostic efficacy of serum AsAGP levels in classifying the severity of liver fibrosis and differentiating liver cirrhosis (LC) in patients with chronic hepatitis B (CHB) from...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical medicine 2023-01, Vol.12 (2), p.712
Hauptverfasser:	Lee, Yoonseok, Bae, Seryun, Kim, Ji Hoon, Kwak, Minjung, Jeon, So Yeon, Kim, Taehyung, Yim, Sun Young, Lee, Young-Sun, Jung, Young Kul, Seo, Yeon Seok, Yim, Hyung Joon, Yeon, Jong Eun, Byun, Kwan Soo
Format:	Artikel
Sprache:	eng
Schlagworte:	Accuracy Acids Biomarkers Biopsy Clinical medicine Diabetes Glycoproteins Hepatitis B Hypertension Laboratories Liver cancer Liver cirrhosis Liver diseases Patients
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!